KEMIFARMA Consulting ApS: Financial statements 2022
CVR: 34709955
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
KEMIFARMA Consulting ApS (CVR 34709955) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 1,088,484 and a net result of DKK 189,396 compared with DKK 410,239 the year before. Equity in the 2022 report amounted to DKK 3,338,457. The solvency ratio was 95.8%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 1,088,484
- Profit/Loss
- DKK 189,396
- Equity
- DKK 3,338,457
- Total Assets
- DKK 3,483,182
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 1.1M | 189K | 3.3M | 1 |
| 2021 | - | -122K | 410K | 3.1M | - |
| 2020 | - | -15K | 392K | 2.8M | - |
| 2019 | - | -32K | 176K | 2.4M | - |
| 2018 | - | -23K | -79K | 2.3M | - |
Official annual report
Keep an eye on KEMIFARMA Consulting ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
KEMIFARMA Consulting ApS has published its annual report for 2021. Gross profit came to DKK -122,398, and the net result was DKK 410,239.
On January 21, 2022, the company changed its name from KEMIFARMA HOLDING ApS to KEMIFARMA Consulting ApS.
About KEMIFARMA Consulting ApS
KEMIFARMA Consulting ApS is a Danish company of the type Anpartsselskab based in Kgs. Lyngby, founded in 2012. The company is registered under the industry Anden teknisk rådgivning. The company was previously named KEMIFARMA HOLDING ApS. The management consists of Christian Hede-Andersen. The company is owned by Christian Hede-Andersen. The company has 1 employee (2023). In 2025, the company reported a gross profit of DKK -57,469 and a net result of DKK 541,385 compared with DKK -378,700 the year before. Equity in the 2025 report amounted to DKK 3,414,022.
